Prof. Dr Diane Harper | University of MIchigan | United States
Prof. Dr. Diane M. Harper is a globally recognized physician-scientist, educator, and leader in women’s health, family medicine, and preventive oncology. She earned her SB and SM degrees in Chemical Engineering and Polymerics from the Massachusetts Institute of Technology (MIT), followed by her MD and MPH in Biostatistics/Epidemiology from the University of Kansas Medical School. Complementing her medical and public health expertise, she completed numerous prestigious postgraduate fellowships and executive leadership programs, including the Executive Leadership in Academic Medicine (ELAM) Program, University of Michigan Ross School of Business Leadership Development, and US PHS Primary Care Fellowship in Washington, D.C. Over her distinguished career, Dr. Harper has held senior academic and administrative appointments at leading institutions including Dartmouth College, University of Missouri–Kansas City, University of Louisville, and currently the University of Michigan, where she serves as a Professor of Family Medicine, Obstetrics and Gynecology, and Women’s and Gender Studies, and Affiliate Faculty in Biomedical Engineering. Her interdisciplinary expertise bridges medicine, engineering, and public health to improve women’s health outcomes worldwide. Internationally acclaimed for her pioneering work on Human Papillomavirus (HPV) and cervical cancer prevention, Dr. Harper has been instrumental in the development and clinical validation of HPV vaccines, advancing screening technologies, and establishing evidence-based guidelines for HPV-associated disease management. Her research spans clinical trials, shared decision-making, health equity, and policy reform, emphasizing underserved and physically disabled populations.
Featured Publications
Quinn, J. A., Munoz, F. M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., … & Harper, D. M. (2016). Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine, 34(49), 6047–6056.
Harper, D. M., DeMars, L. R. (2017). HPV vaccines – A review of the first decade. Gynecologic Oncology, 146(1), 196–204.
Tota, J. E., Struyf, F., Merikukka, M., Gonzalez, P., Kreimer, A. R., Bi, D., … & Harper, D. M. (2017). Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials. Journal of the National Cancer Institute, 109(7), djw300.
Gorin, S. S., Jimbo, M., Heizelman, R., Harmes, K. M., & Harper, D. M. (2021). The future of cancer screening after COVID‐19 may be at home. Wiley Periodicals, Inc.
Dykens, J. A., Peterson, C. E., Holt, H. K., & Harper, D. M. (2023). Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally. Frontiers in Public Health, 11, 1067299.